-+ 0.00%
-+ 0.00%
-+ 0.00%

Jacobson Pharma releases FY2026 ESG report

PUBT·07/16/2026 12:45:03
Listen to the news
Jacobson Pharma releases FY2026 ESG report
  • Jacobson Pharma released its 2025/2026 ESG report, resetting climate targets to align with Hong Kong’s 2050 carbon-neutrality goal.
  • Completed its first climate scenario analysis, flagging typhoons, flooding, rising temperatures, tighter regulation, investor scrutiny as key risks.
  • Expanded Scope 3 greenhouse gas emissions disclosure, aiming to increase transparency across its value chain.
  • Reported 0 product recalls for safety or health reasons, 0 data breaches, 0 corruption-related legal cases; anti-corruption training completion reached 100%.
  • Allocated HKD 119,600 to charitable initiatives; maintained 0 work-related fatalities for a third consecutive year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobson Pharma Corporation Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260716-12247295), on July 16, 2026, and is solely responsible for the information contained therein.